FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308840650> ?p ?o ?g. }

• W4308840650 endingPage "088532822211391" @default.
• W4308840650 startingPage "088532822211391" @default.
• W4308840650 abstract "It is well known that Glycyrrhetnic acid (GA) has significant liver-targeting and anti-inflammatory effects. Syringopicroside (SYR) and Hydroxytyrosol (HT), the active components of the Chinese herb Syringa oblata Lindl, have earned great reputation for their potential in preventing or treating viral hepatitis type B. Therefore, we loaded SYR and HT into GA-conjugated PEG-PLGA, so that they could target the liver in additional to exerting their own pharmacological effects in a synergistic. However, the in vivo targeting and the low bioavailability of SYR and HT pose a huge challenge. Therefore, we synthesized GA-conjugated multi-component nano-drug delivery system (SH-GPP). SH-GPP had a regular spherical shape with a uniform size distribution of 110.5 ± 3.18 nm. We further evaluated the effects of SH-GPP in vitro and in vivo. In the in vivo experiment, we evaluated the following parameters: the serum ALT and AST values; liver tissue homogenate MDA and SOD; HE staining of the pathological liver sections; and the liver coefficient. In the in vitro studies, the following parameters were evaluated: cellular uptake of SH-GPP; wound healing/scratch assay; cellular apoptosis; cell cycle; HBsAg; and HBeAg content. SH-GPP had better anti-hepatitis B effect than Syringopicroside and hydroxytyrosol (SH) and NPP alone. The targeting ability of GA enabled HT and SYR in GPP to reach the liver accurately, and played a synergistic role to maximize their therapeutic effects. This study provides a novel strategy against hepatitis B virus, and also provides a feasible scheme for improving the low bioavailability of the active components of traditional Chinese medicine." @default.
• W4308840650 created "2022-11-17" @default.
• W4308840650 creator A5046643126 @default.
• W4308840650 creator A5049679010 @default.
• W4308840650 creator A5058375796 @default.
• W4308840650 creator A5062753900 @default.
• W4308840650 creator A5078190142 @default.
• W4308840650 creator A5079974007 @default.
• W4308840650 creator A5089110764 @default.
• W4308840650 date "2022-11-12" @default.
• W4308840650 modified "2023-10-03" @default.
• W4308840650 title "A novel strategy against hepatitis B virus: Glycyrrhetnic acid conjugated multi-component synergistic nano-drug delivery system for targeted therapy" @default.
• W4308840650 cites W1593644920 @default.
• W4308840650 cites W1973356985 @default.
• W4308840650 cites W1989230986 @default.
• W4308840650 cites W2323071323 @default.
• W4308840650 cites W2325456070 @default.
• W4308840650 cites W2462566639 @default.
• W4308840650 cites W2472666821 @default.
• W4308840650 cites W2518888171 @default.
• W4308840650 cites W2886608317 @default.
• W4308840650 cites W2895633239 @default.
• W4308840650 cites W2945470910 @default.
• W4308840650 cites W2951467967 @default.
• W4308840650 cites W2954685870 @default.
• W4308840650 cites W2960940959 @default.
• W4308840650 cites W2968290901 @default.
• W4308840650 cites W2996247702 @default.
• W4308840650 cites W2997617992 @default.
• W4308840650 cites W2999332476 @default.
• W4308840650 cites W3007847150 @default.
• W4308840650 cites W3022312067 @default.
• W4308840650 cites W3037771387 @default.
• W4308840650 cites W3039464929 @default.
• W4308840650 cites W3081410196 @default.
• W4308840650 cites W3097320089 @default.
• W4308840650 cites W3112395725 @default.
• W4308840650 cites W3134042055 @default.
• W4308840650 cites W3142073308 @default.
• W4308840650 cites W3181593500 @default.
• W4308840650 cites W3203689329 @default.
• W4308840650 cites W4220871258 @default.
• W4308840650 cites W4233213502 @default.
• W4308840650 doi "https://doi.org/10.1177/08853282221139132" @default.
• W4308840650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36373787" @default.
• W4308840650 hasPublicationYear "2022" @default.
• W4308840650 type Work @default.
• W4308840650 citedByCount "3" @default.
• W4308840650 countsByYear W43088406502023 @default.
• W4308840650 crossrefType "journal-article" @default.
• W4308840650 hasAuthorship W4308840650A5046643126 @default.
• W4308840650 hasAuthorship W4308840650A5049679010 @default.
• W4308840650 hasAuthorship W4308840650A5058375796 @default.
• W4308840650 hasAuthorship W4308840650A5062753900 @default.
• W4308840650 hasAuthorship W4308840650A5078190142 @default.
• W4308840650 hasAuthorship W4308840650A5079974007 @default.
• W4308840650 hasAuthorship W4308840650A5089110764 @default.
• W4308840650 hasConcept C150903083 @default.
• W4308840650 hasConcept C178790620 @default.
• W4308840650 hasConcept C185592680 @default.
• W4308840650 hasConcept C190283241 @default.
• W4308840650 hasConcept C202751555 @default.
• W4308840650 hasConcept C203014093 @default.
• W4308840650 hasConcept C207001950 @default.
• W4308840650 hasConcept C2522874641 @default.
• W4308840650 hasConcept C2775940106 @default.
• W4308840650 hasConcept C2777382497 @default.
• W4308840650 hasConcept C2777410769 @default.
• W4308840650 hasConcept C2779820397 @default.
• W4308840650 hasConcept C2780593183 @default.
• W4308840650 hasConcept C55493867 @default.
• W4308840650 hasConcept C71924100 @default.
• W4308840650 hasConcept C86803240 @default.
• W4308840650 hasConcept C98274493 @default.
• W4308840650 hasConceptScore W4308840650C150903083 @default.
• W4308840650 hasConceptScore W4308840650C178790620 @default.
• W4308840650 hasConceptScore W4308840650C185592680 @default.
• W4308840650 hasConceptScore W4308840650C190283241 @default.
• W4308840650 hasConceptScore W4308840650C202751555 @default.
• W4308840650 hasConceptScore W4308840650C203014093 @default.
• W4308840650 hasConceptScore W4308840650C207001950 @default.
• W4308840650 hasConceptScore W4308840650C2522874641 @default.
• W4308840650 hasConceptScore W4308840650C2775940106 @default.
• W4308840650 hasConceptScore W4308840650C2777382497 @default.
• W4308840650 hasConceptScore W4308840650C2777410769 @default.
• W4308840650 hasConceptScore W4308840650C2779820397 @default.
• W4308840650 hasConceptScore W4308840650C2780593183 @default.
• W4308840650 hasConceptScore W4308840650C55493867 @default.
• W4308840650 hasConceptScore W4308840650C71924100 @default.
• W4308840650 hasConceptScore W4308840650C86803240 @default.
• W4308840650 hasConceptScore W4308840650C98274493 @default.
• W4308840650 hasFunder F4320323085 @default.
• W4308840650 hasLocation W43088406501 @default.
• W4308840650 hasLocation W43088406502 @default.
• W4308840650 hasOpenAccess W4308840650 @default.
• W4308840650 hasPrimaryLocation W43088406501 @default.
• W4308840650 hasRelatedWork W2123661325 @default.
• W4308840650 hasRelatedWork W2355866703 @default.

• next